Autopsy report · NCT06633562
A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults
Cause of deathRegulatory or ethics
“The trial was terminated early due to regulatory constraints preventing the continuation of study conduct.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 10 months before it stopped.
- 29 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Lohocla Research Corporation
- Sponsor type
- Industry
- Conditions
- Healthy; Safety Evaluation of Escalating Doses; Tolerability
- Interventions
- Nezavist SDD; Placebo
- Participants
- 29
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)
“According to study protocol the trial was terminated because the recruitment of trial participants was insufficient.” - Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
“The study was terminated because of slow enrollment. The decision to terminate the trial was not based on any safety or efficacy concerns.” - Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.
“The study was terminated due to additional regulatory requirements that could not be completed within the established academic timeline. As a result, continuation of the study was not feasible.” - Adverse Events of MRI With Abandoned Leads
“The study was stopped due to challenges with recruitment and insufficient insurance coverage for the required procedures, which prevented continuation of the trial.” - The EMS Sleep Health Study: A Randomized Controlled Trial
“Trial enrollment terminated early due to end of funding period.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.